David S. Pisetsky, M.D.
NPI 1912089020ActiveIndividual· Allergy & Immunology· Durham, NC
Allergy & Immunology (M.D.) in Durham, North Carolina, licensed in NC and NY, with an NPI issued in October 2006. Otsuka Pharmaceutical Development & Commercialization, Inc. was the largest of 2 companies reporting payments in 2025, $9,700 in all, mostly consulting fees.
Overview
| NPI | 1912089020 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Oct 19, 2006 |
| Last updated in NPPES | Sep 11, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Allergy & Immunology Primary | 207K00000X | 22806 | NC |
| Internal Medicine, Rheumatology | 207RR0500X | 22806 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Industry payments (Open Payments)
- 2025$9,700 · 13 payments from 2 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $9,574 | 12 |
| Astrazeneca Pharmaceuticals LP | $126.29 | 1 |
What the 2025 payments were for
- Consulting Fee$8,307 · 4 payments
- Travel and Lodging$1,078 · 5 payments
- Food and Beverage$315.19 · 4 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Allergy & Immunology providers in Durham
- 1669713590
- 1598393134
- 1972583656
- 1528233947
- 1013412477
- 1750606653
- 1154484939
- 1245294206
- 1386728251
- 1700949583
- 1497075659